Precision Business Insights has published a report on the global cancer vaccines market, estimating its value at USD 2.14 Billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of XX% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/cancer-vaccines-market

Market Definition:

Biological preparations known as cancer vaccines are made to encourage the immune system to identify and combat cancerous cells. Cancer vaccines, in contrast to conventional vaccines that prevent infectious diseases, can either prevent specific malignancies (like the hepatitis B and HPV vaccines) or cure cancers that have already occurred by assisting the immune system in identifying antigens unique to tumors.

Drivers:

1) Rising cancer incidence worldwide.
2) Advancements in immunotherapy and biotechnology.

The global cancer vaccines market segmentation:

1) By Vaccine Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines, Others,
2) By Indication: Prostate Cancer, Bladder Cancer, Melanoma, Cervical Cancer, Others.
3) By Technology Type: Recombinant Cancer Vaccines, Whole-cell Cancer Vaccines, Viral Vector and DNA Cancer Vaccines, Other Technologies.

Regional Overview:
The report also examines the current concerns and their Future Effects on the cancer vaccines market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the cancer vaccines market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

·         North America (U.S., Canada)

·         Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

·         Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)

·         Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)

·         Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The competitive landscape is dominated by major players like Merck & Co. Inc. GlaxoSmithKline plc (GSK) Moderna Inc. Pfizer Inc. Sanofi S.A. AstraZeneca Plc Bristol-Myers Squibb Company Dynavax Technologies Corporation Amgen Inc. Ferring B.V. Dendreon Pharmaceuticals LLC BioNTech SE Gritstone bio Inc. Vaccinogen Inc. OSE Immunotherapeutics SA Transgene S.A. Anixa Biosciences Inc. Imugene Ltd. eTheRNA Immunotherapies NV NantKwest Inc. Ultimovacs ASA ISA Pharmaceuticals BV Wantai BioPharm Walvax Biotechnology Co. Ltd. Centre of Molecular Immunology Synthaverse S.A. Serum Institute of India Pvt. Ltd. Avax Technologies Inc. Gradalis Inc. Heat Biologics Inc. Nykode Therapeutics AS Agenus Inc. OncoSec Medical Incorporated Northwest Biotherapeutics Inc. Vaccitech plc CureVac N.V. IO Biotech A/S Biobohemia AB AiVita Biomedical Co. Ltd. Sellas Life Sciences Group Inc. TapImmune Inc. VAXIMM AG BrightPath Biotherapeutics Inc. Boston Biomedical Inc. Barinthus Biotherapeutics plc NexImmune Inc. Scancell Holdings PLC

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747